Version 7.4 change log
Version 7.4 change log
• RE909: medication stacking and combination classifications and penalties refer to the ESC Controlled Medications Library. Applicable violations may range from Low to Medium to Severe (high); stacking is not automatically Medium.
• Added an explanation of the Library’s red medical-snake stacking callout. Existing A/B/C classification icons remain separate.
• CM802.9: clarified handling of trainer-requested additional (C) samples collected at a show: handoff to the ESC veterinarian, tagging and ESC laboratory processing are required for the findings to be considered. Official A/B sampling and review procedures remain separate. Required sample tubes must be at least 70% full. Both B-sample analysis fee entries now use market rate based on the chosen secondary laboratory’s processing fee; ESC provides the accused two certified laboratory choices.
• RS403: clarified the Give Back marketing grant practice, coverage of upcoming-year operating costs, and adjustment of the reinvestment percentage based on prior-year proceeds. A grant and the 25% reference reinvestment rate are not guaranteed; approved uses remain unchanged, and continued ESC Network sanctioning is required to receive a grant.
• Updated the version and effective date. No medication-specific dose, concentration, withdrawal or washout changes awaiting approval are included. All unrelated rules are retained.
